Fecal microbiota transplantation in disease therapy
- PMID: 31968211
- DOI: 10.1016/j.cca.2019.12.010
Fecal microbiota transplantation in disease therapy
Abstract
Fecal microbiota transplantation (FMT) is the introduction (transplantation) of gut microbiota obtained from the faeces of a healthy donor into the patient's gastrointestinal tract. Most often, such therapy is used the treatment of gastrointestinal diseases caused by the activity of pathogenic or conditionally pathogenic microorganisms, however, recently an increasing number of studies have reported the use of fecal microbiota transplantation for the treatment of diseases such as metabolic syndrome, diabetes, cancer and Parkinson's disease. This review article presents the results of studies concerning the impact of FMT on weight gain, immunological response and the treatment of neurological and gastrointestinal diseases and cancer. The procedure of fecal microbiota transplantation and possible side effects that may appear in FMT recipients are also described.
Keywords: FMT; Fecal microbiota transplantation; Gastrointestinal diseases; Gut microbiota; Immunological response; Neurological diseases.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Fecal microbiota transplantation: Review and update.J Formos Med Assoc. 2019 Mar;118 Suppl 1:S23-S31. doi: 10.1016/j.jfma.2018.08.011. Epub 2018 Sep 1. J Formos Med Assoc. 2019. PMID: 30181015 Review.
-
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases.Dig Dis. 2016;34(3):279-85. doi: 10.1159/000443362. Epub 2016 Mar 30. Dig Dis. 2016. PMID: 27027524 Review.
-
Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders.Future Microbiol. 2020 Aug;15:1173-1183. doi: 10.2217/fmb-2020-0061. Future Microbiol. 2020. PMID: 32954843 Review.
-
Safety and feasibility of faecal microbiota transplantation for patients with Parkinson's disease: a protocol for a self-controlled interventional donor-FMT pilot study.BMJ Open. 2023 Oct 5;13(10):e071766. doi: 10.1136/bmjopen-2023-071766. BMJ Open. 2023. PMID: 37798034 Free PMC article. Clinical Trial.
-
Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans.Arch Med Res. 2017 Nov;48(8):766-773. doi: 10.1016/j.arcmed.2017.11.006. Epub 2017 Nov 26. Arch Med Res. 2017. PMID: 29183720 Review.
Cited by
-
Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation.Front Microbiol. 2021 Apr 12;12:658292. doi: 10.3389/fmicb.2021.658292. eCollection 2021. Front Microbiol. 2021. PMID: 33912150 Free PMC article.
-
Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy.Front Immunol. 2022 Aug 8;13:877939. doi: 10.3389/fimmu.2022.877939. eCollection 2022. Front Immunol. 2022. PMID: 36003378 Free PMC article. Review.
-
Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis.Open Life Sci. 2023 Oct 17;18(1):20220741. doi: 10.1515/biol-2022-0741. eCollection 2023. Open Life Sci. 2023. PMID: 37872967 Free PMC article. Review.
-
Randomised, placebo-controlled, double-blinded trial of fecal microbiota transplantation in severe obesity: a study protocol.BMJ Open. 2023 Dec 27;13(12):e073242. doi: 10.1136/bmjopen-2023-073242. BMJ Open. 2023. PMID: 38151280 Free PMC article.
-
Nutrition and Cancer Risk from the Viewpoint of the Intestinal Microbiome.Nutrients. 2021 Sep 23;13(10):3326. doi: 10.3390/nu13103326. Nutrients. 2021. PMID: 34684330 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources